Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Premera Blue Cross	5.01.624 Alpha1-Proteinase InhibitorsPayerPolicy · PREMERA-5-01-624-ALPHA1-PROTEINASE-INHIBITORS-1D95962995	New policy
Aug 2, 2026	Premera Blue Cross	5.01.587 Hereditary AngioedemaPayerPolicy · PREMERA-5-01-587-HEREDITARY-ANGIOEDEMA-B3A44B6645	New policy
Aug 2, 2026	Premera Blue Cross	5.01.572 Coverage Criteria for Excluded and Non-Formulary DrugsPayerPolicy · PREMERA-5-01-572-COVERAGE-CRITERIA-FOR-EXCLUDED-AND-NON-FORMULARY-DR-CEAFF4FD29	New policy
Aug 2, 2026	Premera Blue Cross	5.01.565 Pharmacotherapy of Multiple SclerosisPayerPolicy · PREMERA-5-01-565-PHARMACOTHERAPY-OF-MULTIPLE-SCLEROSIS-36E2DEE4A3	New policy
Aug 2, 2026	Premera Blue Cross	5.01.564 Pharmacotherapy of Miscellaneous Autoimmune DiseasesPayerPolicy · PREMERA-5-01-564-PHARMACOTHERAPY-OF-MISCELLANEOUS-AUTOIMMUNE-DISEASE-6CAD1FB73A	New policy
Aug 2, 2026	Premera Blue Cross	5.01.560 Excessively High Cost Drug Products with Lower CostPayerPolicy · PREMERA-5-01-560-EXCESSIVELY-HIGH-COST-DRUG-PRODUCTS-WITH-LOWER-COST-080D4CB728	New policy
Aug 2, 2026	Premera Blue Cross	5.01.503 Migraine and Cluster Headache MedicationsPayerPolicy · PREMERA-5-01-503-MIGRAINE-AND-CLUSTER-HEADACHE-MEDICATIONS-6B2507AF77	New policy
Aug 2, 2026	Premera Blue Cross	15.01.039 Fecal Analysis in the Diagnosis of Intestinal DysbiosisPayerPolicy · PREMERA-15-01-039-FECAL-ANALYSIS-IN-THE-DIAGNOSIS-OF-INTESTINAL-DYSB-66B19C941C	New policy
Aug 2, 2026	Premera Blue Cross	15.01.014 Coronavirus Testing in the Outpatient SettingPayerPolicy · PREMERA-15-01-014-CORONAVIRUS-TESTING-IN-THE-OUTPATIENT-SETTING-B59E642A8E	New policy
Aug 2, 2026	Premera Blue Cross	7.03.15 Urinary Test for Renal Allograft DysfunctionPayerPolicy · PREMERA-7-03-15-URINARY-TEST-FOR-RENAL-ALLOGRAFT-DYSFUNCTION-AC089DF60C	New policy
Aug 2, 2026	Premera Blue Cross	7.01.97 Intracoronary Drug Delivery Balloon ProceduresPayerPolicy · PREMERA-7-01-97-INTRACORONARY-DRUG-DELIVERY-BALLOON-PROCEDURES-DAA6A1B09F	New policy
Aug 2, 2026	Premera Blue Cross	7.01.596 Adjunctive Techniques for Screening, Surveillance, andPayerPolicy · PREMERA-7-01-596-ADJUNCTIVE-TECHNIQUES-FOR-SCREENING-SURVEILLANCE-AN-E83B6622F5	New policy
Aug 2, 2026	Premera Blue Cross	7.01.587 Open and Thoracoscopic Approaches to Treat Atrial FibrillatioPayerPolicy · PREMERA-7-01-587-OPEN-AND-THORACOSCOPIC-APPROACHES-TO-TREAT-ATRIAL-F-3CC6606399	New policy
Aug 2, 2026	Premera Blue Cross	7.01.172 Surgical Left Atrial Appendage Occlusion Devices forPayerPolicy · PREMERA-7-01-172-SURGICAL-LEFT-ATRIAL-APPENDAGE-OCCLUSION-DEVICES-FO-00384BF04F	New policy
Aug 2, 2026	Premera Blue Cross	5.01.635 Pharmacologic Treatment of Epidermolysis BullosaPayerPolicy · PREMERA-5-01-635-PHARMACOLOGIC-TREATMENT-OF-EPIDERMOLYSIS-BULLOSA-37C504B02E	New policy
Aug 2, 2026	Premera Blue Cross	5.01.633 Intraarticular CorticosteroidsPayerPolicy · PREMERA-5-01-633-INTRAARTICULAR-CORTICOSTEROIDS-D50F9CD872	New policy
Aug 2, 2026	Premera Blue Cross	5.01.608 Pharmacologic Treatment of Postpartum DepressionPayerPolicy · PREMERA-5-01-608-PHARMACOLOGIC-TREATMENT-OF-POSTPARTUM-DEPRESSION-0D1F088C86	New policy
Aug 2, 2026	Premera Blue Cross	5.01.570 Pharmacologic Treatment of Duchenne Muscular DystrophyPayerPolicy · PREMERA-5-01-570-PHARMACOLOGIC-TREATMENT-OF-DUCHENNE-MUSCULAR-DYSTRO-B6B8A6CB4D	New policy
Aug 2, 2026	Premera Blue Cross	5.01.569 Pharmacotherapy of Type 1 and Type 2 Diabetes MellitusPayerPolicy · PREMERA-5-01-569-PHARMACOTHERAPY-OF-TYPE-1-AND-TYPE-2-DIABETES-MELLI-4BD4D3B1E8	New policy
Aug 2, 2026	Premera Blue Cross	4.01.502 Surgical Interruption of Pelvic Nerve Pathways for ChronicPayerPolicy · PREMERA-4-01-502-SURGICAL-INTERRUPTION-OF-PELVIC-NERVE-PATHWAYS-FOR-8F839DE838	New policy
Aug 2, 2026	Premera Blue Cross	3.03.03 Prescription Digital Therapeutics for Attention DeficitPayerPolicy · PREMERA-3-03-03-PRESCRIPTION-DIGITAL-THERAPEUTICS-FOR-ATTENTION-DEFI-3D9C010583	New policy
Aug 2, 2026	Premera Blue Cross	7.01.168 Cryoablation, Radiofrequency Ablation, and Laser AblationPayerPolicy · PREMERA-7-01-168-CRYOABLATION-RADIOFREQUENCY-ABLATION-AND-LASER-ABLA-328110409F	New policy
Aug 2, 2026	Premera Blue Cross	11.01.525 (effective September 1, 2026) Site of Service AmbulatoryPayerPolicy · PREMERA-11-01-525-EFFECTIVE-SEPTEMBER-1-2026-SITE-OF-SERVICE-AMBULAT-BBF146D31C	New policy
Aug 2, 2026	Premera Blue Cross	11.01.508 Skilled Home Health Care ServicesPayerPolicy · PREMERA-11-01-508-SKILLED-HOME-HEALTH-CARE-SERVICES-9B0D5728DE	New policy
Aug 2, 2026	Premera Blue Cross	1.01.529 Durable Medical EquipmentPayerPolicy · PREMERA-1-01-529-DURABLE-MEDICAL-EQUIPMENT-02100AC607	New policy
Aug 2, 2026	Premera Blue Cross	7.01.574 Implantable Peripheral Nerve Stimulation for the TreatmentPayerPolicy · PREMERA-7-01-574-IMPLANTABLE-PERIPHERAL-NERVE-STIMULATION-FOR-THE-TR-995630A1E4	New policy
Aug 2, 2026	Premera Blue Cross	7.01.601 Endovascular Stent Grafts for Abdominal Aortic AneurysmsPayerPolicy · PREMERA-7-01-601-ENDOVASCULAR-STENT-GRAFTS-FOR-ABDOMINAL-AORTIC-ANEU-AE8E1E5914	New policy
Aug 2, 2026	Premera Blue Cross	5.01.586 Intravenous Anesthetics for the Treatment of ChronicPayerPolicy · PREMERA-5-01-586-INTRAVENOUS-ANESTHETICS-FOR-THE-TREATMENT-OF-CHRONI-291EA794E8	New policy
Aug 2, 2026	Premera Blue Cross	5.01.573 Pharmacotherapy of Perinatal/Infantile and JuvenilePayerPolicy · PREMERA-5-01-573-PHARMACOTHERAPY-OF-PERINATAL-INFANTILE-AND-JUVENILE-88DF85C4D0	New policy
Aug 2, 2026	Premera Blue Cross	2.01.107 Fractional Carbon Dioxide (CO2) Laser Ablation TreatmentPayerPolicy · PREMERA-2-01-107-FRACTIONAL-CARBON-DIOXIDE-CO2-LASER-ABLATION-TREATM-54EDF4B88B	New policy
Aug 2, 2026	Premera Blue Cross	11.01.525 Site of Service Ambulatory Service Center (ASC) SelectPayerPolicy · PREMERA-11-01-525-SITE-OF-SERVICE-AMBULATORY-SERVICE-CENTER-ASC-SELE-3B10CCE670	New policy
Aug 2, 2026	Premera Blue Cross	10.01.503 General Anesthesia and Facility Services Related toPayerPolicy · PREMERA-10-01-503-GENERAL-ANESTHESIA-AND-FACILITY-SERVICES-RELATED-T-606B8A1E6C	New policy
Aug 2, 2026	Premera Blue Cross	1.03.04 Powered Exoskeleton for Ambulation in Patients With LowerPayerPolicy · PREMERA-1-03-04-POWERED-EXOSKELETON-FOR-AMBULATION-IN-PATIENTS-WITH-27EA63983C	New policy
Aug 2, 2026	Premera Blue Cross	7.01.92 Cryoablation of Tumors Located in the Kidney, Lung, BreastPayerPolicy · PREMERA-7-01-92-CRYOABLATION-OF-TUMORS-LOCATED-IN-THE-KIDNEY-LUNG-BR-69A994DBF5	New policy
Aug 2, 2026	Premera Blue Cross	7.01.605 (effective September 4, 2026) Shoulder Open ProceduresPayerPolicy · PREMERA-7-01-605-EFFECTIVE-SEPTEMBER-4-2026-SHOULDER-OPEN-PROCEDURES-8DD11BBA2E	New policy
Aug 2, 2026	Premera Blue Cross	7.01.597 Radiofrequency Volumetric Tissue Reduction for NasalPayerPolicy · PREMERA-7-01-597-RADIOFREQUENCY-VOLUMETRIC-TISSUE-REDUCTION-FOR-NASA-478A3700EB	New policy
Aug 2, 2026	Premera Blue Cross	5.01.647 Medical Necessity Criteria for Custom Open FormularyPayerPolicy · PREMERA-5-01-647-MEDICAL-NECESSITY-CRITERIA-FOR-CUSTOM-OPEN-FORMULAR-E2DDFF60EE	New policy
Aug 2, 2026	Premera Blue Cross	5.01.620 Vascular Endothelial Growth Factor (VEGF) Receptor InhibitorsPayerPolicy · PREMERA-5-01-620-VASCULAR-ENDOTHELIAL-GROWTH-FACTOR-VEGF-RECEPTOR-IN-18E8200D7F	New policy
Aug 2, 2026	Premera Blue Cross	5.01.619 Intravitreal and Suprachoroidal CorticosteroidsPayerPolicy · PREMERA-5-01-619-INTRAVITREAL-AND-SUPRACHOROIDAL-CORTICOSTEROIDS-32B875FD4E	New policy
Aug 2, 2026	Premera Blue Cross	5.01.618 Selective Estrogen Receptor Modulators and Down RegulatorsPayerPolicy · PREMERA-5-01-618-SELECTIVE-ESTROGEN-RECEPTOR-MODULATORS-AND-DOWN-REG-9196028597	New policy
Aug 2, 2026	Premera Blue Cross	5.01.540 Miscellaneous Oncology DrugsPayerPolicy · PREMERA-5-01-540-MISCELLANEOUS-ONCOLOGY-DRUGS-96D4375759	New policy
Aug 2, 2026	Premera Blue Cross	5.01.642 Gene Therapies for Rare DiseasesPayerPolicy · PREMERA-5-01-642-GENE-THERAPIES-FOR-RARE-DISEASES-E2CCEFC6A0	New policy
Aug 2, 2026	Premera Blue Cross	7.01.85 Electrical Stimulation of the Spine as an Adjunct toPayerPolicy · PREMERA-7-01-85-ELECTRICAL-STIMULATION-OF-THE-SPINE-AS-AN-ADJUNCT-TO-FCC16BB17C	New policy
Aug 2, 2026	Premera Blue Cross	2.04.514 Protein Biomarkers for Diagnosis and Risk AssessmentPayerPolicy · PREMERA-2-04-514-PROTEIN-BIOMARKERS-FOR-DIAGNOSIS-AND-RISK-ASSESSMEN-863AA6D325	New policy
Aug 2, 2026	Premera Blue Cross	2.04.123 Serum Biomarker Panel Testing for Systemic Lupus ErythematosuPayerPolicy · PREMERA-2-04-123-SERUM-BIOMARKER-PANEL-TESTING-FOR-SYSTEMIC-LUPUS-ER-5516BB917D	New policy
Aug 2, 2026	Premera Blue Cross	2.02.518 Transcatheter Tricuspid Valve Repair or ReplacementPayerPolicy · PREMERA-2-02-518-TRANSCATHETER-TRICUSPID-VALVE-REPAIR-OR-REPLACEMENT-F91825A599	New policy
Aug 2, 2026	Premera Blue Cross	7.01.601 (effective November 6, 2026) Endovascular Stent GraftsPayerPolicy · PREMERA-7-01-601-EFFECTIVE-NOVEMBER-6-2026-ENDOVASCULAR-STENT-GRAFTS-B32036076A	New policy
Aug 2, 2026	Premera Blue Cross	8.01.11 Transcatheter Arterial Chemoembolization (TACE) to TreatPayerPolicy · PREMERA-8-01-11-TRANSCATHETER-ARTERIAL-CHEMOEMBOLIZATION-TACE-TO-TRE-65977DC412	New policy
Aug 2, 2026	Premera Blue Cross	7.01.604 Gastroesophageal Reflux Surgery in AdultsPayerPolicy · PREMERA-7-01-604-GASTROESOPHAGEAL-REFLUX-SURGERY-IN-ADULTS-2DA9F8D30B	New policy
Aug 2, 2026	Premera Blue Cross	7.01.595 Carpal Tunnel Release Surgical TechniquesPayerPolicy · PREMERA-7-01-595-CARPAL-TUNNEL-RELEASE-SURGICAL-TECHNIQUES-59E4D9B19B	New policy